Open AccessEfficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder
Author(s) -
P Boyer,
Cécile Vialet,
Eunhee Hwang,
Karen A. Tourian
Publication year - 2015
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.14m01711
Subject(s) - placebo , major depressive disorder , depression (economics) , rating scale , medicine , psychiatry , antidepressant , psychology , hamilton rating scale for depression , cognition , anxiety , developmental psychology , alternative medicine , pathology , economics , macroeconomics
To examine long-term (11-month) antidepressant efficacy of desvenlafaxine 50 mg/d across a broad range of clinical and functional outcomes in patients with major depressive disorder.